by adminAdrianRamirez | May 16, 2013 | Company News, Kannalife Sciences, Press Releases, Wellness Managed Services
AN DIEGO, May 16, 2013 (GLOBE NEWSWIRE) — Medical Marijuana Inc. (OTC:MJNA) is pleased to inform shareholders that it has completed and posted its 1st Quarter 2013 Audited Financial Statements and Corporate Disclosure. The disclosure can be found by clicking on...
by adminAdrianRamirez | Apr 30, 2013 | Company News, Industry Updates, Kannalife Sciences, Press Releases
SAN DIEGO, April 30, 2013 /PRNewswire/ — Medical Marijuana Inc. (OTC: MJNA) To The Shareholders of Medical Marijuana Inc.: From: Michelle Sides, Chairman, Chief Operating Officer and Shareholder It has become apparent that the Company needs to pause momentarily...
by adminAdrianRamirez | Apr 11, 2013 | Company News, Kannalife Sciences, Press Releases
SAN DIEGO, April 11, 2013 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and hemp industry innovator, today is pleased to pre-announce its fourth quarter earnings. The company earned net income of approximately $5.52 million on gross...
by adminAdrianRamirez | Apr 4, 2013 | Company News, Industry Updates, Kannalife Sciences, Press Releases
NEW YORK, April 4, 2013 (GLOBE NEWSWIRE) — KannaLife Sciences, Inc. (“KannaLife”) announces its collaboration with two experienced drug discovery organizations: Advanced Neural Dynamics and IteraMed. KannaLife will fund a new drug discovery project...
by adminAdrianRamirez | Mar 20, 2013 | Company News, Industry Updates, Kannalife Sciences, Press Releases
Company to invest and finance local manufacturers, distributors, retail stores and additional brands- Distribution partners set to launch online and retail sales in April PR Newswire SAN DIEGO, March 20, 2013 SAN DIEGO, March 20, 2013 /PRNewswire/ — Medical...
by adminAdrianRamirez | Mar 7, 2013 | Company News, Industry Updates, Kannalife Sciences, Press Releases
NEW YORK, March 7, 2013 /PRNewswire/ — KannaLife Sciences, Inc. (“KannaLife”) the phyto-medical company that specializes in the research & development of pharmacological products derived from botanical sources, announced today the entry into...